| Joseph R Bertino, MD
 |
Professor, Medicine, RWJMS
The Cancer Institute of New Jersey (CINJ)
195 Little Albany Street, Room 3033
New Brunswick, NJ 08903
bertinoj@umdnj.edu
|
Degree - Fellowship from USPHS Univ of Washington School of Med
- Resident from Veterans Administration Hospital
- Internship from Graduate Hospital of the Univ of PA
- MD from Downstate Medical Center
- Undergraduate School from Cornell University
Positions - Interim Director, Stem Cell Institute of New Jersey (10/2007 - Present)
Department of Medicine
SCINJ - Interim Director, The Cancer Institute of New Jersey (03/2007 - 09/2008)
Department of Medicine
CINJ - University Professor of Medicine & Pharmacology (01/2002 - Present)
Department of Medicine
UMDNJ-RWJMS - Chief Scientific Officer, The Cancer Institute of New Jersey (01/2002 - Present)
Department of Medicine
CINJ - Associate Director, The Cancer Institute of NJ (01/2002 - 03/2007)
Department of Medicine
CINJ
Honors - University Professor
UMDNJ-RWJMS (2002) - Freundlich Leadership Award
Lymphoma Research Foundation (2004) - Key to the Cure Award
Lymphoma Research Foundation (2006) - ASCO Statesman Award
ASCO (2007) - Bob Pinedo Cancer Care Prize for Contributions to Improvement in the Care of Cancer Patients
Medical Knowledge Institute (2007)
Society - American Association for Cancer Research (AACR) (2002 - Present)
- American Federation for Clinical Research (AFCR) (2002 - Present)
- American Society for Clinical Investigation (ASCI) (2002 - Present)
- American Society for Clinical Oncology (ASCO) (2002 - Present)
- American Society for Pharmacology & Experimental Therapeutics (ASPET) (2002 - Present)
- American Society of Biological Chemists (ASBC) (2002 - Present)
- American Society of Hematology (ASH) (2002 - Present)
- Association of American Physicians (AAP) (2002 - Present)
Publications - Mishra PJ, Mishra PJ, Banerjee D, Bertino JR MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics Cell Cycle. 20084; 7:853-8. Cited in PubMed; PMID 18414050
- Haller DG, Cassidy J, Clarke SJ, Cunningham D, Van Cutsem E, Hoff PM, Rothenberg ML, Saltz LB, Schmoll HJ, Allegra C, Bertino JR, Douillard YU, Gustavsson BG, Milano G, O'Connell M, Rustum Y, Tabernero J, Gilberg F, Sirzen F, Twelves C Potential regional differences for the tolerability profiles of fluoropyrimidines J Clin Oncol. 20085; 26 (13):2118-23. Cited in PubMed; PMID 18445840
- Yang R, Li WW, Hoang BH, Kim H, Banerjee D, Kheradpour A, Healey JH, Meyers PA, Bertino JR and Gorlick R Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier BMC Cancer. 20085; 1 (8):124. Cited in PubMed; PMID 18452618
- Dabrowska M, Hendrikx PJ, Skierski J, Malinowska M, Bertino JR, Rode W EGFP Fluorescence as an indicator of cancer cells response to methotrexate Eur J Pharmacol. 20071; 555 (2-3):93-9. Cited in PubMed; PMID 17141212
- Mayer-Kuckuk P., Doubrovin M., Bidaut L., Budak-Alpdogan T., Cai S., Hubbard V., Alpdogan O., van den Brink M., Bertino J.R., Blasberg R.G., Banerjee D., Gelovani J Molecular Imaging reveals skeletal engraftment sites of transplanted bone marrow cells Cell Transplantation. 2006; 15 (1):75-82. Cited in PubMed; PMID 16700332
- Russo Angelo J., Magro Pellegrino G., Hu Zhen, Li Wei-Wei, Peters Rowayda, Mandola Jennifer, Banerjee Debabrata, Bertino Joseph R E2F-1 Overexpression in U2OS Cells Increases Cyclin B1 Levels and cdc2 Kinase Activity and Sensitizes Cells to Antimitotic Agents Cancer Research. 20067; 66 (14):7253-60. Cited in PubMed; PMID 16849574
- Longo-Sorbello Giuseppe S.A., Chen Bobin, Budak-Alpdogan Tulin, Bertino Joseph R Role of Pemetrexed in Non-Small Cell Lung Cancer Cancer Investigation. 20079; 25 (1):59-66. Cited in PubMed; PMID 17364559
- Picinich SC, Mishra PJ, Mishra PJ, Glod J, Banerjee D The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy Expert Opin Biol Ther. 20077; 7:965-73.
- Mishra PJ, Humeniuk R, Mishra PJ, Longo-Sorbello GS, Banerjee D, Bertino JR A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance Proc Natl Acad Sci . 20078; 104 (33):13513-8. Cited in PubMed; PMID 17686970
- Humeniuk R, Menon LG, Mishra PJ, Saydam G, Longo-Sorbello GS, Elisseyeff Y, Lewis LD, Aracil M, Jimeno J, Bertino JR, Banerjee D Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity Leukemia. 20078;
- Bertino JR, Banerjee D, Mishra PJ. Pharmacogenomics of microRNA: a miRSNP towards individualized Pharmacogenomics . 200712; 8 (12):1625-1627. Cited in PubMed; PMID 18085993
Research - Chemotherapy; genomics; pharmacology; and the relationship between tumor suppressor gene abnormalities and drug resistance.
|
Request an Appointment